SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?

To: Kelton who wrote (298)6/29/1999 3:20:00 PM
From: hd99glide  Respond to of 337
 
VGI isn't going to be sold any time soon. I think that Stevens just got himself misquoted. It would be folly to expect to get paid true value BEFORE FDA approval this fall. What's it worth? My guess is that with FDA in hand later this fall, it would be worth minimum of $30 and perhaps up to $50. The price would go up rapidly from that point as US sales begin to kick in.



To: Kelton who wrote (298)7/6/1999 3:02:00 PM
From: jim sykes  Read Replies (1) | Respond to of 337
 
Anybody heard rumours about Stevens leaving the company? I hear if
this is the case it will benefit the share price.I'm hearing news
in 48 hours.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News